Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:51 UTC |
---|
Update Date | 2023-02-21 17:18:22 UTC |
---|
HMDB ID | HMDB0014997 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Penicillamine |
---|
Description | Penicillamine is only found in individuals that have used or taken this drug. It is the most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. [PubChem]Penicillamine is a chelating agent recommended for the removal of excess copper in patients with Wilson's disease. From in vitro studies which indicate that one atom of copper combines with two molecules of penicillamine. Penicillamine also reduces excess cystine excretion in cystinuria. This is done, at least in part, by disulfide interchange between penicillamine and cystine, resulting in formation of penicillamine-cysteine disulfide, a substance that is much more soluble than cystine and is excreted readily. Penicillamine interferes with the formation of cross-links between tropocollagen molecules and cleaves them when newly formed. The mechanism of action of penicillamine in rheumatoid arthritis is unknown although it appears to suppress disease activity. Unlike cytotoxic immunosuppressants, penicillamine markedly lowers IgM rheumatoid factor but produces no significant depression in absolute levels of serum immunoglobulins. Also unlike cytotoxic immunosuppressants which act on both, penicillamine in vitro depresses T-cell activity but not B-cell activity. |
---|
Structure | InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8) |
---|
Synonyms | Value | Source |
---|
(+-)-Penicillamine | ChEBI | 2-Amino-3-mercapto-3-methylbutyric acid | ChEBI | 3,3-Dimethylcysteine | ChEBI | beta-Mercaptovaline | ChEBI | D,L-Penicillamine | ChEBI | DL-3-Mercaptovaline | ChEBI | DL-beta-Mercaptovaline | ChEBI | 2-Amino-3-mercapto-3-methylbutyrate | Generator | b-Mercaptovaline | Generator | Β-mercaptovaline | Generator | DL-b-Mercaptovaline | Generator | DL-Β-mercaptovaline | Generator | beta,beta-Dimethylcysteine | HMDB, MeSH | beta-Thiovaline | HMDB | D-Mercaptovaline | HMDB | D-Penamine | HMDB | D-Penicilamine | HMDB | D-Penicillamine | HMDB, MeSH | D-Penicyllamine | HMDB | Dimethylcysteine | HMDB, MeSH | L-Penicillamine | HMDB | Penicillamin | HMDB | Penicillamina | HMDB | Penicilllamine | HMDB | D-3-Mercaptovaline | MeSH, HMDB | Cuprenil | MeSH, HMDB | D 3 Mercaptovaline | MeSH, HMDB | Cuprimine | MeSH, HMDB | Penicillaminate, copper | MeSH, HMDB | D Penicillamine | MeSH, HMDB | Metalcaptase | MeSH, HMDB | Copper penicillaminate | MeSH, HMDB | Mercaptovaline | MeSH, HMDB | beta,beta Dimethylcysteine | MeSH, HMDB |
| Show more...
---|
Chemical Formula | C5H11NO2S |
---|
Average Molecular Weight | 149.211 |
---|
Monoisotopic Molecular Weight | 149.051049291 |
---|
IUPAC Name | 2-amino-3-methyl-3-sulfanylbutanoic acid |
---|
Traditional Name | (+-)-penicillamine |
---|
CAS Registry Number | 52-67-5 |
---|
SMILES | CC(C)(S)C(N)C(O)=O |
---|
InChI Identifier | InChI=1S/C5H11NO2S/c1-5(2,9)3(6)4(7)8/h3,9H,6H2,1-2H3,(H,7,8) |
---|
InChI Key | VVNCNSJFMMFHPL-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as valine and derivatives. Valine and derivatives are compounds containing valine or a derivative thereof resulting from reaction of valine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Valine and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Valine or derivatives
- Alpha-amino acid
- Branched fatty acid
- Thia fatty acid
- Methyl-branched fatty acid
- Fatty acid
- Fatty acyl
- Amino acid
- Alkylthiol
- Carboxylic acid
- Monocarboxylic acid or derivatives
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Organic nitrogen compound
- Primary aliphatic amine
- Carbonyl group
- Organic oxygen compound
- Amine
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 198.5 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 4.65 g/L | Not Available | LogP | -1.9 | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | | Show more...
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Penicillamine,1TMS,isomer #1 | CC(C)(S)C(N)C(=O)O[Si](C)(C)C | 1304.5 | Semi standard non polar | 33892256 | Penicillamine,1TMS,isomer #2 | CC(C)(S[Si](C)(C)C)C(N)C(=O)O | 1491.2 | Semi standard non polar | 33892256 | Penicillamine,1TMS,isomer #3 | CC(C)(S)C(N[Si](C)(C)C)C(=O)O | 1432.8 | Semi standard non polar | 33892256 | Penicillamine,2TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(N)C(=O)O[Si](C)(C)C | 1491.7 | Semi standard non polar | 33892256 | Penicillamine,2TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(N)C(=O)O[Si](C)(C)C | 1530.7 | Standard non polar | 33892256 | Penicillamine,2TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(N)C(=O)O[Si](C)(C)C | 1943.1 | Standard polar | 33892256 | Penicillamine,2TMS,isomer #2 | CC(C)(S)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1429.4 | Semi standard non polar | 33892256 | Penicillamine,2TMS,isomer #2 | CC(C)(S)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1402.3 | Standard non polar | 33892256 | Penicillamine,2TMS,isomer #2 | CC(C)(S)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1629.1 | Standard polar | 33892256 | Penicillamine,2TMS,isomer #3 | CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O | 1569.3 | Semi standard non polar | 33892256 | Penicillamine,2TMS,isomer #3 | CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O | 1481.0 | Standard non polar | 33892256 | Penicillamine,2TMS,isomer #3 | CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O | 1745.5 | Standard polar | 33892256 | Penicillamine,2TMS,isomer #4 | CC(C)(S)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1574.1 | Semi standard non polar | 33892256 | Penicillamine,2TMS,isomer #4 | CC(C)(S)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1485.7 | Standard non polar | 33892256 | Penicillamine,2TMS,isomer #4 | CC(C)(S)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1743.3 | Standard polar | 33892256 | Penicillamine,3TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1593.2 | Semi standard non polar | 33892256 | Penicillamine,3TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1585.8 | Standard non polar | 33892256 | Penicillamine,3TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(N[Si](C)(C)C)C(=O)O[Si](C)(C)C | 1592.8 | Standard polar | 33892256 | Penicillamine,3TMS,isomer #2 | CC(C)(S)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1591.5 | Semi standard non polar | 33892256 | Penicillamine,3TMS,isomer #2 | CC(C)(S)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1598.1 | Standard non polar | 33892256 | Penicillamine,3TMS,isomer #2 | CC(C)(S)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1707.8 | Standard polar | 33892256 | Penicillamine,3TMS,isomer #3 | CC(C)(S[Si](C)(C)C)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1736.5 | Semi standard non polar | 33892256 | Penicillamine,3TMS,isomer #3 | CC(C)(S[Si](C)(C)C)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1643.2 | Standard non polar | 33892256 | Penicillamine,3TMS,isomer #3 | CC(C)(S[Si](C)(C)C)C(C(=O)O)N([Si](C)(C)C)[Si](C)(C)C | 1709.9 | Standard polar | 33892256 | Penicillamine,4TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1767.1 | Semi standard non polar | 33892256 | Penicillamine,4TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1739.3 | Standard non polar | 33892256 | Penicillamine,4TMS,isomer #1 | CC(C)(S[Si](C)(C)C)C(C(=O)O[Si](C)(C)C)N([Si](C)(C)C)[Si](C)(C)C | 1576.6 | Standard polar | 33892256 | Penicillamine,1TBDMS,isomer #1 | CC(C)(S)C(N)C(=O)O[Si](C)(C)C(C)(C)C | 1534.9 | Semi standard non polar | 33892256 | Penicillamine,1TBDMS,isomer #2 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O | 1745.3 | Semi standard non polar | 33892256 | Penicillamine,1TBDMS,isomer #3 | CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O | 1671.2 | Semi standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O[Si](C)(C)C(C)(C)C | 1968.4 | Semi standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O[Si](C)(C)C(C)(C)C | 2013.7 | Standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N)C(=O)O[Si](C)(C)C(C)(C)C | 2127.3 | Standard polar | 33892256 | Penicillamine,2TBDMS,isomer #2 | CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1847.5 | Semi standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #2 | CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1877.0 | Standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #2 | CC(C)(S)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 1939.2 | Standard polar | 33892256 | Penicillamine,2TBDMS,isomer #3 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O | 2062.0 | Semi standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #3 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O | 1938.8 | Standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #3 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O | 1978.5 | Standard polar | 33892256 | Penicillamine,2TBDMS,isomer #4 | CC(C)(S)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2015.7 | Semi standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #4 | CC(C)(S)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1934.0 | Standard non polar | 33892256 | Penicillamine,2TBDMS,isomer #4 | CC(C)(S)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 1967.3 | Standard polar | 33892256 | Penicillamine,3TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2253.1 | Semi standard non polar | 33892256 | Penicillamine,3TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2228.5 | Standard non polar | 33892256 | Penicillamine,3TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(N[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C | 2003.9 | Standard polar | 33892256 | Penicillamine,3TBDMS,isomer #2 | CC(C)(S)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2244.1 | Semi standard non polar | 33892256 | Penicillamine,3TBDMS,isomer #2 | CC(C)(S)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2266.6 | Standard non polar | 33892256 | Penicillamine,3TBDMS,isomer #2 | CC(C)(S)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2054.0 | Standard polar | 33892256 | Penicillamine,3TBDMS,isomer #3 | CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2407.5 | Semi standard non polar | 33892256 | Penicillamine,3TBDMS,isomer #3 | CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2282.1 | Standard non polar | 33892256 | Penicillamine,3TBDMS,isomer #3 | CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2051.5 | Standard polar | 33892256 | Penicillamine,4TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2629.0 | Semi standard non polar | 33892256 | Penicillamine,4TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2527.0 | Standard non polar | 33892256 | Penicillamine,4TBDMS,isomer #1 | CC(C)(S[Si](C)(C)C(C)(C)C)C(C(=O)O[Si](C)(C)C(C)(C)C)N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2064.9 | Standard polar | 33892256 |
| Show more...
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-00dl-9300000000-53220ef4bf765d5867dc | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (1 TMS) - 70eV, Positive | splash10-0fka-9500000000-e42c54b7496cbff2d761 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (TBDMS_1_2) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Penicillamine GC-MS (TBDMS_1_3) - 70eV, Positive | Not Available | 2021-11-04 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 10V, Positive-QTOF | splash10-0udi-1900000000-5ce6ffc67f24493fa02a | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 20V, Positive-QTOF | splash10-0ufr-5900000000-ac76f8c72b2335916905 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 40V, Positive-QTOF | splash10-00di-9000000000-2211209d297edcae5f72 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 10V, Negative-QTOF | splash10-01ot-0900000000-9a13581ec86df368b000 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 20V, Negative-QTOF | splash10-03dj-1900000000-4c84239071ebf03d19f9 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 40V, Negative-QTOF | splash10-0089-9100000000-13c27853348bf51a69c1 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 10V, Positive-QTOF | splash10-0uxr-2900000000-33459beee34fc2a2011b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 20V, Positive-QTOF | splash10-0uk9-6900000000-960c6308ce3675c6c507 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 40V, Positive-QTOF | splash10-004l-9000000000-488ef4ddf13c867f5d33 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 10V, Negative-QTOF | splash10-0002-0900000000-5bc8874919ea1e2a5fda | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 20V, Negative-QTOF | splash10-001i-9000000000-942ac689538269d6ca7b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Penicillamine 40V, Negative-QTOF | splash10-001i-9000000000-942ac689538269d6ca7b | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
IR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M-H]-) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+H]+) | 2023-02-03 | FELIX lab | View Spectrum | Predicted IR Spectrum | IR Ion Spectrum (Predicted IRIS Spectrum, Adduct: [M+Na]+) | 2023-02-03 | FELIX lab | View Spectrum |
| Show more...
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | Not Available |
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00859 | | details | Urine | Expected but not Quantified | Not Quantified | Not Available | Not Available | Taking drug identified by DrugBank entry DB00859 | | details |
|
---|
Abnormal Concentrations |
---|
| Not Available |
---|
Associated Disorders and Diseases |
---|
Disease References | None |
---|
Associated OMIM IDs | None |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 4565 |
---|
KEGG Compound ID | Not Available |
---|
BioCyc ID | Not Available |
---|
BiGG ID | Not Available |
---|
Wikipedia Link | Penicillamine |
---|
METLIN ID | Not Available |
---|
PubChem Compound | Not Available |
---|
PDB ID | Not Available |
---|
ChEBI ID | 50868 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | Not Available |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
Material Safety Data Sheet (MSDS) | Not Available |
---|
General References | - Munro R, Capell HA: Penicillamine. Br J Rheumatol. 1997 Jan;36(1):104-9. [PubMed:9117147 ]
- Suarez-Almazor ME, Spooner C, Belseck E: Penicillamine for rheumatoid arthritis. Cochrane Database Syst Rev. 2000;(2):CD001460. [PubMed:10796440 ]
- Walshe JM: The story of penicillamine: a difficult birth. Mov Disord. 2003 Aug;18(8):853-9. [PubMed:12889074 ]
- WALSHE JM: Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487-95. [PubMed:13362281 ]
- Gong Y, Frederiksen SL, Gluud C: D-penicillamine for primary biliary cirrhosis. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004789. [PubMed:15495127 ]
- Duruelo J, Cuende E, Preciado E, Diaz de Otazu R, Vesga JC: [Microscopic polyangiitis in a patient with systemic sclerosis]. Reumatol Clin. 2005 Oct;1(3):177-9. doi: 10.1016/S1699-258X(05)72739-X. Epub 2008 Dec 20. [PubMed:21794259 ]
- Masson MJ, Teranishi M, Shenton JM, Uetrecht JP: Investigation of the involvement of macrophages and T cells in D-penicillamine-induced autoimmunity in the Brown Norway rat. J Immunotoxicol. 2004 Apr;1(2):79-93. doi: 10.1080/15476910490496258. [PubMed:18958641 ]
|
---|